Quinn Opportunity Partners LLC Vera Therapeutics, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 19,000 shares of VERA stock, worth $376,010. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,000Holding current value
$376,010% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$113 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$94.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$66.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$57.8 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $535M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...